These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2412005)
21. Development and trends in the drug treatment of essential hypertension. van Zwieten PA J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322 [TBL] [Abstract][Full Text] [Related]
23. Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects. Atwal KS; O'Reilly BC; Ruby EP; Turk CF; Aberg G; Asaad MM; Bergey JL; Moreland S; Powell JR J Med Chem; 1987 Apr; 30(4):627-35. PubMed ID: 2435902 [TBL] [Abstract][Full Text] [Related]
24. Local and cellular Ca2+ transients in smooth muscle of pressurized rat resistance arteries during myogenic and agonist stimulation. Miriel VA; Mauban JR; Blaustein MP; Wier WG J Physiol; 1999 Aug; 518 ( Pt 3)(Pt 3):815-24. PubMed ID: 10420017 [TBL] [Abstract][Full Text] [Related]
25. [Interactions between antihypertensive drugs]. Takagi M; Matsuoka H Nihon Rinsho; 1992 May; 50 Suppl():23-27. PubMed ID: 1355126 [No Abstract] [Full Text] [Related]
26. Pharmacological basis for the therapeutic applications of slow-channel blocking drugs. Singh BN Angiology; 1982 Aug; 33(8):492-515. PubMed ID: 7051905 [TBL] [Abstract][Full Text] [Related]
27. [Effect of methyclothiazide on the entry of calcium into vascular smooth muscle cells]. Colas B; Colas JL; Masson H; Slama M; Collin T; Andrejak M Arch Mal Coeur Vaiss; 2000 Aug; 93(8):901-4. PubMed ID: 10989727 [TBL] [Abstract][Full Text] [Related]
28. Tailoring the antihypertensive drug regimen. Amadio P; Cummings DM; Amadio PB Am Fam Physician; 1986 Aug; 34(2):157-70. PubMed ID: 2875638 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological basis for use of calcium antagonists in hypertension. Scriabine A; Kazda S Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846 [TBL] [Abstract][Full Text] [Related]
30. Systemic and ocular vascular roles of the antiglaucoma agents beta-adrenergic antagonists and Ca2+ entry blockers. Yu DY; Su EN; Cringle SJ; Alder VA; Yu PK; DeSantis L Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S214-22. PubMed ID: 10416766 [TBL] [Abstract][Full Text] [Related]
31. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers. Höcht C; Bertera FM; Mayer MA; Taira CA Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):199-211. PubMed ID: 20095790 [TBL] [Abstract][Full Text] [Related]
32. Effects of antihypertensive drugs on lipid metabolism. Leren P Clin Ther; 1987; 9(3):326-32. PubMed ID: 2886221 [TBL] [Abstract][Full Text] [Related]
33. [Interactions between anti-hypertensive and non-antihypertensive drugs]. Sugimoto T; Matsuoka H Nihon Rinsho; 1992 May; 50 Suppl():28-33. PubMed ID: 1355128 [No Abstract] [Full Text] [Related]